301 related articles for article (PubMed ID: 32271510)
1. Partial nephrectomy provides equivalent oncologic outcomes and better renal function preservation than radical nephrectomy for pathological T3a renal cell carcinoma: A meta-analysis.
Deng H; Fan Y; Yuan F; Wang L; Hong Z; Zhan J; Zhang W
Int Braz J Urol; 2021; 47(1):46-60. PubMed ID: 32271510
[TBL] [Abstract][Full Text] [Related]
2. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the long-term follow-up and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm renal cell carcinoma: a systematic review and meta-analysis.
Jiang YL; Peng CX; Wang HZ; Qian LJ
BMC Urol; 2019 Jun; 19(1):48. PubMed ID: 31174522
[TBL] [Abstract][Full Text] [Related]
4. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
Patel SH; Uzzo RG; Larcher A; Peyronnet B; Lane BR; Pruthi D; Reddy M; Capitanio U; Joshi S; Noyes S; Eldefrawy A; Ghali F; Meagher MF; Hamilton ZA; Yim K; Nasseri R; Bradshaw AW; Dey S; Kirmiz S; Wan F; Liss MA; Bensalah K; Montorsi F; Derweesh IH
Clin Genitourin Cancer; 2020 Dec; 18(6):e723-e729. PubMed ID: 32600941
[TBL] [Abstract][Full Text] [Related]
5. Comparison of oncologic outcomes between partial and radical nephrectomy for localized renal cell carcinoma: A systematic review and meta-analysis.
Gu L; Ma X; Li H; Chen L; Xie Y; Li X; Gao Y; Zhang Y; Zhang X
Surg Oncol; 2016 Dec; 25(4):385-393. PubMed ID: 27916170
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis for comparison of partial nephrectomy
Liu H; Kong QF; Li J; Wu YQ; Pan KH; Xu B; Wang YL; Chen M
Transl Androl Urol; 2021 Mar; 10(3):1170-1178. PubMed ID: 33850752
[TBL] [Abstract][Full Text] [Related]
7. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.
Shvero A; Nativ O; Abu-Ghanem Y; Zilberman D; Zaher B; Levitt M; Fridman E; Portnoy O; Ramon J; Dotan ZA
Clin Genitourin Cancer; 2018 Jun; 16(3):e613-e617. PubMed ID: 29174471
[TBL] [Abstract][Full Text] [Related]
8. Partial nephrectomy versus radical nephrectomy for large (≥ 7 cm) renal tumors: A systematic review and meta-analysis.
Deng W; Chen L; Wang Y; Liu X; Wang G; Fu B
Urol Oncol; 2019 Apr; 37(4):263-272. PubMed ID: 30704957
[TBL] [Abstract][Full Text] [Related]
9. Partial nephrectomy versus radical nephrectomy for cT2 or greater renal tumors: a systematic review and meta-analysis.
Li J; Zhang Y; Teng Z; Han Z
Minerva Urol Nefrol; 2019 Oct; 71(5):435-444. PubMed ID: 31287256
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review and Meta-Analysis of Comparative Studies Reporting Perioperative Outcomes of Robot-Assisted Partial Nephrectomy Versus Open Partial Nephrectomy.
Xia L; Wang X; Xu T; Guzzo TJ
J Endourol; 2017 Sep; 31(9):893-909. PubMed ID: 27305835
[TBL] [Abstract][Full Text] [Related]
11. Oncologic and Functional Outcomes after Partial Nephrectomy Versus Radical Nephrectomy in T1b Renal Cell Carcinoma: A Multicenter, Matched Case-Control Study in Korean Patients.
Jang HA; Kim JW; Byun SS; Hong SH; Kim YJ; Park YH; Yang KS; Cho S; Cheon J; Kang SH
Cancer Res Treat; 2016 Apr; 48(2):612-20. PubMed ID: 26044158
[TBL] [Abstract][Full Text] [Related]
12. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
13. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract][Full Text] [Related]
14. Is Robotic Partial Nephrectomy Safe for T3a Renal Cell Carcinoma? Experience of a High-Volume Center.
Andrade HS; Zargar H; Akca O; Kara O; Caputo PA; Ramirez D; Andrés G; Stein RJ; Chueh SJ; Kaouk JH
J Endourol; 2017 Feb; 31(2):153-157. PubMed ID: 27881027
[TBL] [Abstract][Full Text] [Related]
15. Recurrence after radical and partial nephrectomy in high complex renal tumor using propensity score matched analysis.
Kim H; Kim JK; Ye C; Choi JH; Lee H; Oh JJ; Lee S; Hong SK; Byun SS
Sci Rep; 2021 Feb; 11(1):2919. PubMed ID: 33536492
[TBL] [Abstract][Full Text] [Related]
16. Partial and Radical Nephrectomy Provides Equivalent Oncologic Outcomes in pT3a Renal Cell Carcinoma: A Population-Based Study.
Tian J; Zeng X; Wan J; Gan J; Ke C; Guan W; Hu Z; Yang C
Front Oncol; 2021; 11():819098. PubMed ID: 35155208
[TBL] [Abstract][Full Text] [Related]
17. Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.
Mouracade P; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Malkoc E; Kaouk JH
World J Urol; 2017 Sep; 35(9):1425-1433. PubMed ID: 28197727
[TBL] [Abstract][Full Text] [Related]
18. Oncological and functional efficacy of nephron-sparing surgery versus radical nephrectomy in renal cell carcinoma stages ≥cT1b: a single institution, matched analysis.
Veys R; Abdollah F; Briganti A; Albersen M; Poppel HV; Joniau S
Cent European J Urol; 2018; 71(1):48-57. PubMed ID: 29732207
[TBL] [Abstract][Full Text] [Related]
19. Off-clamp partial nephrectomy has a positive impact on short- and long-term renal function: a systematic review and meta-analysis.
Deng W; Liu X; Hu J; Chen L; Fu B
BMC Nephrol; 2018 Jul; 19(1):188. PubMed ID: 30064370
[TBL] [Abstract][Full Text] [Related]
20. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.
An JY; Ball MW; Gorin MA; Hong JJ; Johnson MH; Pavlovich CP; Allaf ME; Pierorazio PM
Urology; 2017 Feb; 100():151-157. PubMed ID: 27889493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
